Lunder · Current vascular pharmacology 2019 · narrative review · n=?

Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall.

Cited 17 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review describing pathophysiological mechanisms and therapeutic concepts without systematic review methodology or primary data

PubMed 29412116 · doi:10.2174/1570161116666180206113755 · record verified 2026-08-28

What was done

This narrative review describes the molecular pathways linking hyperglycemia, insulin resistance, oxidative stress, inflammation, and endothelial dysfunction to arterial wall damage in diabetes mellitus. It summarizes existing and potential therapeutic approaches specifically aimed at targeting and improving arterial wall dysfunction to prevent microvascular and macrovascular complications.

What was found

The abstract describes pathophysiological concepts and therapeutic rationale without reporting quantitative findings, empirical data, or numerical outcomes.

Why it matters

It emphasizes that glycemic control alone is insufficient to prevent macrovascular complications and argues that treatments directly protecting arterial wall structure and function should be prioritized in diabetes management.

Limits

This is a narrative review lacking a systematic search protocol, meta-analytic pooling, or formal quality appraisal of cited evidence. The abstract provides no original clinical trial data or quantitative effect estimates.

Cited by